SCLX Scilex Holding Company

  1. Stocks
  2. Healthcare
  3. NASDAQ: SCLX

Price (delayed)

$6.84

Market cap

$58.08M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$40.47

Enterprise value

$161.09M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 8
Highlights
The quick ratio rose by 40% since the previous quarter and by 17% year-on-year
SCLX's debt has surged by 118% year-on-year but it is down by 20% since the previous quarter
SCLX's gross profit is down by 45% year-on-year but it is up by 2.8% since the previous quarter
SCLX's equity is down by 20% YoY and by 20% from the previous quarter
The gross margin has declined by 17% year-on-year and by 8% since the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - General
Peers: OPK ORGO

Key stats

What are the main financial stats of SCLX

SCLX stock price

How has the Scilex Holding stock price performed over time
Intraday
-7.44%
1 week
-18.96%
1 month
-0.29%
1 year
-36.19%
YTD
-43.93%
QTD
-12.31%

Financial performance

How have Scilex Holding's revenue and profit performed over time
Revenue
$33.86M
Gross profit
$20.2M
Operating income
-$350.28M
Net income
-$375.92M
Gross margin
59.7%
Net margin
-1,110.2%
SCLX's gross profit is down by 45% year-on-year but it is up by 2.8% since the previous quarter
Scilex Holding's revenue has decreased by 33% YoY but it has increased by 12% from the previous quarter
The gross margin has declined by 17% year-on-year and by 8% since the previous quarter
The operating margin is up by 10% since the previous quarter

Price vs fundamentals

How does SCLX's price correlate with its fundamentals

Growth

What is Scilex Holding's growth rate over time

Valuation

What is Scilex Holding stock price valuation
P/E
N/A
P/B
N/A
P/S
1.39
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.76
The EPS has contracted by 11% from the previous quarter
SCLX's equity is down by 20% YoY and by 20% from the previous quarter
The price to sales (P/S) is 92% lower than the 5-year quarterly average of 18.3 and 58% lower than the last 4 quarters average of 3.3
Scilex Holding's revenue has decreased by 33% YoY but it has increased by 12% from the previous quarter

Efficiency

How efficient is Scilex Holding business performance
The ROA has plunged by 108% YoY but it has grown by 18% from the previous quarter
The ROS has grown by 6% from the previous quarter

Dividends

What is SCLX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SCLX.

Financial health

How did Scilex Holding financials performed over time
The total assets is 46% smaller than the total liabilities
The total liabilities has soared by 89% year-on-year but it is down by 5% since the previous quarter
The quick ratio rose by 40% since the previous quarter and by 17% year-on-year
SCLX's debt is 142% greater than its equity
SCLX's debt has surged by 118% year-on-year but it is down by 20% since the previous quarter
Scilex Holding's debt to equity has plunged by 83% YoY but it has increased by 33% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.